Imago BioSciences, Inc. Retained Earnings
Imago BioSciences, Inc. had Retained Earnings of -$159.56 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-11-09
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$159.56M.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$142.79M.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$129.05M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$112.65M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2022-09-30 | -$159.56M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$142.79M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$129.05M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$112.65M 10-Q · filed 2022-11-09 |
| 2021-09-30 | -$97.93M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$86.26M 10-Q · filed 2021-08-19 |
| 2020-12-31 | -$70.34M 10-K · filed 2022-03-24 |